FINANCIAL REPORTING VALUATION

The FASB and the SEC are continually expanding the use of fair value measurements. The evolution from historic cost basis to fair value measurement has greatly increased the role of valuation specialists in the financial reporting process. Naturally, increased reliance on fair value measurements results in increased scrutiny from auditors and the SEC.

BVA regularly performs fair value analyses for the following purposes:

• Purchase price allocations including valuation of intangible assets under FASB ASC topic 805 (formerly SFAS 141R)
• Goodwill impairment testing under FASB ASC topic 350 (formerly SFAS 142)
• Impairment testing of long-lived assets under FASB ASC topic 360 (formerly SFAS 144)
• Stock-based compensation under FASB ASC topic 718 (formerly SFAS 123R)
• Determining fair value of financial assets (including derivatives and swaps) under FASB ASC topic 820 (formerly SFAS 157)

Privately-held companies are also faced with the task of determining the value of their stock prior to setting the stock option exercise price as required by IRC §409A.  BVA regularly performs valuation of companies for this purpose, including venture-backed companies with multiple rounds of preferred equity financing.

Our clients include public and private companies and our valuations have been reviewed by the SEC and PCAOB.

BVA's professionals have the education, experience, skills and certifications required to provide a quality analysis and are knowledgeable of the financial and valuation standards governing valuations performed for financial reporting.